Table 3 Five-year survival rates among testicular cancer patients from different racial groups, stratified by age, marital status, stage at diagnosis, location, and treatment

All ages

94.4

95.0

92.3

88.8

91.7

(94.1–94.6)

(94.7–95.3)

(91.5–93.0)

(86.6–90.6)

(89.9–93.1)

 0–39

94.4

95.2

92.1.

88.9

92.2

0.003

(94.1–94.7)

(94.9–95.5)

(91.2–92.8)

(86.3–91.1)

(90.3–93.7)

 40–64

94.9

95.3

93.8

88.9

92.3

0.012

(94.4–95.4)

(94.7–95.8)

(91.6–95.4)

(84.2–92.3)

(88.3–94.9)

 65+

82.8

84.1

79.0

46.9

65.6

0.008

(77.4–87.1)

(78.2–88.5)

(57.5–90.5)

(12.7–75.7)

(41.9–81.6)

 Single

92.1

92.9

90.3

86.2

90.0

< 0.001

(91.7–92.5)

(92.4–93.4)

(89.2–91.4)

(83.0–88.8)

(87.4–92.0)

 Married

96.7

97.0

95.6

92.4

93.5

< 0.001

(96.4–97.0)

(96.7–97.4)

(94.5–96.5)

(88.7–94.9)

(90.9–95.4)

 Separated/D/W

90.3

90.8

865

87.8

91.8

0.221

(88.8–91.6)

(89.2–92.2)

(81.3–90.3)

(76.8–93.8)

(80.3–96.7)

 Localized

98.7

98.9

98.2

97.1

97.8

0.002

(98.5–98.9)

(98.6–99.1)

(97.5–98.7)

(94.9–98.3)

(96.2–98.7)

 Regional

94.9

95.3

94.5

87.7

91.0

0.009

(94.3–95.4)

(94.6–95.9)

(92.8–95.8)

(82.0–91.7)

(86.3–94.1)

 Distant

69.6

71.0

67.5

58.4

62.8

< 0.001

(68.2–70.9)

(69.4–72.5)

(64.3–70.4)

(50.6–65.5)

(55.2–69.5)

 Undescended

93.4

93.7

92.0

90.7

95.5

< 0.001

 testis

(91.1–95.2)

(90.7–95.8)

(85.2–95.8)

(75.9–96.6)

(83.8–98.8)

 Descended

95.6

96.8

92.6

91.1

93.1

< 0.001

 testis

(95.2–96.0)

(96.3–97.2)

(91.4–93.6)

(86.5–94.2)

(89.8–95.3)

 Testis (NOS)

93.8

94.3

92.1

87.8

90.7

< 0.001

(93.5–94.1)

(94.0–94.7)

(91.0–93.1)

(84.9–90.1)

(88.5–92.5)

 Seminomas

97.9

98.1

97.3

96.4

96.6

< 0.001

(97.6–98.2)

(97.8–98.4)

(96.5–98.0)

(93.9–97.9)

(94.7–97.8)

 Teratomas

93.0

93.8

90.8

84.7

90.7

< 0.001

(92.5–93.5)

(93.2–94.4)

(89.3–92.1)

(78.8–89.0)

(86.7–93.5)

 ECs

91.2

91.4

90.7

79.2

89.4

< 0.001

(90.4–92.0)

(90.5–92.3)

(88.2–92.8)

(69.0–86.4)

(83.3–93.4)

 Non-seminomas

83.8

87.1

74.5

76.1

75.9

< 0.001

(81.2–86.0)

(84.1–89.5)

(67.8–80.0)

(58.5–87.0)

(58.4–86.9)

 Surgery

97.0

97.2

96.6

91.6

96.7

0.259

(96.5–97.4)

(96.6–97.6)

(94.6–97.9)

(86.2–95.0)

(90.2–98.4)

 Chemotherapy

57.2

56.2

68.7

38.2

58.7

< 0.001

(51.8–62.3)

(49.8–62.0)

(53.1–80.0)

(17.4–58.9)

(80.8–89.5)

 Radiation

83.9

86.9

66.7

50.3

97.3

< 0.001

(72.5–90.9)

(75.0–93.3)

(5.4–94.5)

(0.6–981.2)

(93.5–98.9)

 RS

99.1

99.1

99.5

98.3

98.0

0.007

(98.7–99.4)

(98.6–99.4)

(97.5–99.9)

(93.3–99.6)

(95.0–99.2)

 CS

89.5

89.9

89.6

84.4

83.8

0.003

(88.7–90.3)

(89.0–90.7)

(86.6–92.0)

(77.7–89.3)

(78.4–88.0)

 CR

36.0

44.9

18.8

40.2

40.7

< 0.001

(22.0–50.1)

(26.8–61.4)

(1.1–53.7)

(5.2–75.5)

(19.8–60.8)

 CRS

63.4

65.6

59.5

65.1

43.9

0.946

(58.4–67.9)

(60.0–70.6)

(43.2–72.6)

(37.8–82.8)

(19.9–65.7)